Education
About Us
Working with TipRanks
Follow Us
Gad Berdugo Insider Profile
4 Followers
Gad Berdugo, CFO & SVP at Immune Pharmaceuticals, holds 8.00K shares in Immune Pharmaceuticals (Ticker: IMNPQ). Most recently, Gad Berdugo Bought 8,000 shares of Immune Pharmaceuticals on Dec 03, 2014 for an estimated value of $20.00K.
Gad Berdugo Immune Pharmaceuticals (IMNPQ)CFO & SVP
Immune Pharmaceuticals (IMNPQ)
CFO & SVP
Not Ranked
Gad Berdugo has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Gad Berdugo does not currently own shares as a corporate insider.
A breakdown of Gad Berdugo's holdings
Insider Roles
Gad Berdugo does not currently hold a role as a corporate insider.
Roles that Gad Berdugo holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Gad Berdugo
Gad Berdugo's Trading History
List of latest transactions for each holding click on a transaction to see Gad Berdugo's performance on stock
You May Also Like
Gad Berdugo insider profile FAQ
What is the percentage of profitable transactions made by Gad Berdugo?
The percentage of profitable transactions made by Gad Berdugo is ―.
What is the average return per transaction made by Gad Berdugo?
The average return per transaction made by Gad Berdugo is ―.
What stocks does Gad Berdugo hold?
Gad Berdugo holds: IMNPQ stocks.
What was Gad Berdugo’s latest transaction?
Gad Berdugo latest transaction was an Informative Buy of $20.00K.
What was Gad Berdugo's most profitable transaction?
Gad Berdugo’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Gad Berdugo's role in Immune Pharmaceuticals?
Gad Berdugo's role in Immune Pharmaceuticals is CFO & SVP.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.